Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Current Leases: 2020-2024

Historic Current Leases for Relay Therapeutics (RLAY) over the last 5 years, with Dec 2024 value amounting to $5.7 million.

  • Relay Therapeutics' Current Leases fell 34.11% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 34.11%. This contributed to the annual value of $5.7 million for FY2024, which is 15.37% up from last year.
  • Latest data reveals that Relay Therapeutics reported Current Leases of $5.7 million as of FY2024, which was up 15.37% from $5.0 million recorded in FY2023.
  • Relay Therapeutics' Current Leases' 5-year high stood at $5.7 million during FY2024, with a 5-year trough of $1.5 million in FY2020.
  • Its 3-year average for Current Leases is $5.0 million, with a median of $5.0 million in 2023.
  • Data for Relay Therapeutics' Current Leases shows a peak YoY soared of 131.89% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Relay Therapeutics' Current Leases stood at $1.5 million in 2020, then grew by 21.24% to $1.8 million in 2021, then soared by 131.89% to $4.3 million in 2022, then increased by 16.09% to $5.0 million in 2023, then increased by 15.37% to $5.7 million in 2024.